Skip to search.
 TSX Down 0.81% TSX Ventures Up 0.59%

Amgen Inc. (AMGN)

-NasdaqGS
141.46 Down 3.35(2.31%) Feb 11, 4:00PM EST
|After Hours : 141.95 Up 0.49 (0.35%) Feb 11, 7:49PM EST
Prev Close:144.81
Open:140.75
Bid:139.75 x 100
Ask:142.55 x 300
1y Target Est:184.63
Beta:1.33859
Earnings Date:Apr 19 - Apr 25 (Est.)
Day's Range:140.04 - 143.49
52wk Range:130.09 - 181.81
Volume:4,374,353
Avg Vol (3m):3,772,690
Market Cap:106.66B
P/E (ttm):15.61
EPS (ttm):9.06
Div & Yield:4.00 (2.76%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 2.31%106.66B
JNJDown 0.03%281.40B

Key Statistics

Forward P/E (1 yr):11.69
P/S (ttm):5.04
Ex-Dividend Date:11-Feb-16

Analysts

Annual EPS Est (Dec-16) :10.85
Quarterly EPS Est (Mar-16) :2.59
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback